These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 37162338)

  • 1. Host Immunity and Immunization Strategies for Clostridioides difficile Infection.
    Naz F; Petri WA
    Clin Microbiol Rev; 2023 Jun; 36(2):e0015722. PubMed ID: 37162338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational Aspects of the Immunology of Clostridioides difficile Infection: Implications for Pediatric Populations.
    Kociolek LK; Zackular JP; Savidge T
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S8-S15. PubMed ID: 34791392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.
    Andersson JA; Peniche AG; Galindo CL; Boonma P; Sha J; Luna RA; Savidge TC; Chopra AK; Dann SM
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host Immune Responses to
    Alam MZ; Markantonis JE; Fallon JT
    Trop Med Infect Dis; 2023 Nov; 8(12):. PubMed ID: 38133438
    [No Abstract]   [Full Text] [Related]  

  • 8. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
    Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
    Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
    Sun X; Hirota SA
    Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
    Collins DA; Riley TV
    Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
    [No Abstract]   [Full Text] [Related]  

  • 12. The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity.
    Leslie JL; Vendrov KC; Jenior ML; Young VB
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30700514
    [No Abstract]   [Full Text] [Related]  

  • 13. Aging impairs protective host defenses against Clostridioides (Clostridium) difficile infection in mice by suppressing neutrophil and IL-22 mediated immunity.
    Peniche AG; Spinler JK; Boonma P; Savidge TC; Dann SM
    Anaerobe; 2018 Dec; 54():83-91. PubMed ID: 30099125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.
    Shin JH; High KP; Warren CA
    J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):916-22. PubMed ID: 26809495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?
    Saleh MM; Petri WA
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31570564
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization Strategies Against Clostridioides difficile.
    Campidelli C; Bruxelle JF; Collignon A; Péchiné S
    Adv Exp Med Biol; 2024; 1435():117-150. PubMed ID: 38175474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZupT Facilitates Clostridioides difficile Resistance to Host-Mediated Nutritional Immunity.
    Zackular JP; Knippel RJ; Lopez CA; Beavers WN; Maxwell CN; Chazin WJ; Skaar EP
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32161145
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and treatment of recurrent Clostridioides difficile infection.
    Shin JH; Warren CA
    Curr Opin Infect Dis; 2019 Oct; 32(5):482-489. PubMed ID: 31369420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Navigating changes in
    Durham SH; Le P; Cassano AT
    J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.